PSA screening reduced deaths can miss aggressive cancer

Prostate cancer: should PSA screening be routine?

Does PSA testing reduce prostate cancer mortality? ... But despite recommendations against routine prostate cancer screening for men with no ...

Predictors of Repeated PSA Testing Among Black and White ... - CDC

Screening with prostate-specific antigen (PSA) may decrease mortality. Repeated testing allows for the calculation of PSA velocity (change of ...

Prostate Cancer Screening | Sumner Health Centre

It is possible to reduce prostate cancer specific mortality (the amount of deaths related to prostate cancer directly) by screening but not to improve overall ...

More men diagnosed with advanced prostate cancer as PSA testing ...

As PSA screening for prostate cancer declines, more men are being diagnosed with advanced disease that is less likely to respond to ...

Targeted screening effective in reducing prostate cancer deaths

A new study published in the journal PLOS Medicine shows that the number of prostate cancer deaths could be reduced by a sixth by simply ...

A discussion on controversies and ethical dilemmas in prostate ...

Level 1 evidence from randomised controlled trials suggests a reduction in cancer-specific mortality from PCa screening. However, there could be an ...

After long decline, death rates from prostate cancer stop falling

“There is irrefutable evidence that PSA screening has benefits and does reduce advanced disease and death,” she said. “But there is also ...

New PSA Recommendations: The Debate over Prostate Cancer ...

Crawford and associates estimated the clinical and economic effects of increasing the current 1-year PSA screening interval by 1 to 4 years.

Relationship Between Baseline Prostate-specific Antigen on Cancer ...

In prostate cancer screening, the patient's baseline PSA (prostate-specific antigen) level can be used to guide decisions on when to repeat ...

Risk of prostate cancer and death after benign transurethral ...

Men with low PSA levels and a benign TURP can be reassured about their cancer risk and do not need to be monitored differently than any other ...

Lifetime Benefits and Harms of Prostate-Specific Antigen–Based ...

There was also a strong association between baseline PSA and prostate cancer mortality: 44% of prostate cancer deaths occurred in men with PSA in the top 10% of ...

[Withdrawn] Prostate cancer risk management programme (PCRMP)

To date, there is no evidence screening black men at high risk for the disease will reduce their risk of prostate cancer-related death. 6.3 ...

PSA screening cuts deaths by 20%, says world's largest prostate ...

Screening for prostate cancer can reduce deaths by 20%, according to the results of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Screening for prostate cancer: are organized screening programs ...

They concluded that PSA screening strategies that use higher thresholds for biopsy referral for older men and that screening men with low PSA levels less ...

Prostate Cancer Diagnosis and Staging - Medscape Reference

In a 2010 study, Tang et al concluded that in the 75- to 80-year age group, discontinuation of PSA screening may be safe in African-American men ...

Evolving Recommendations on Prostate Cancer Screening

One would expect screening to reduce mortality 8 or more years after introduction. There have been declines in prostate cancer mortality in more ...

Prostate Cancer Screening and Early Detection

Some low-risk prostate cancers can be carefully followed with active surveillance rather than treated initially with the typical more aggressive measures.

Overview of Prostate Cancer Screening Decision Models

Thus, aggressive screening strategies (particularly with low PSA thresholds for biopsy referral) optimize benefit (i.e., prostate cancer deaths ...

Empirical estimates of prostate cancer overdiagnosis by age and ...

Prostate cancer screening depends on a careful balance of benefits, in terms of reduced prostate cancer mortality, and harms, in terms of ...

Prostate Cancer Screening | AAFP

A Cochrane review of five RCTs concluded that PSA screening does not decrease prostate cancer–specific or overall mortality. Screening ...